Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share
-
Shares outstanding
-
9,036,176
-
Total 13F shares
-
25,495,461
-
Share change
-
-1,694,217
-
Total reported value
-
$241,308,981
-
Price per share
-
$9.53
-
Number of holders
-
57
-
Value change
-
-$36,609,937
-
Number of buys
-
25
-
Number of sells
-
58
Institutional Holders of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) as of Q4 2021
As of 31 Dec 2021,
Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,495,461 shares.
The largest 10 holders included
BAILLIE GIFFORD & CO, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC, ORBIMED ADVISORS LLC, BlackRock Inc., CANADA PENSION PLAN INVESTMENT BOARD, Sumitomo Mitsui Trust Holdings, Inc., VANGUARD GROUP INC, ARK Investment Management LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
57
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.